Patents Assigned to Advanced Viral Research Corp.
-
Patent number: 7074767Abstract: Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.Type: GrantFiled: July 22, 2002Date of Patent: July 11, 2006Assignee: Advanced Viral Research Corp.Inventors: Bernard Friedland, Shalom Z. Hirschman, Irach B. Taraporewala
-
Patent number: 7067139Abstract: A method of treating patients having rheumatoid arthritis by administering Product R, a peptide-nucleic acid preparation, is disclosed.Type: GrantFiled: May 21, 1999Date of Patent: June 27, 2006Assignee: Advanced Viral Research Corp.Inventor: Shalom Z. Hirschman
-
Patent number: 6921542Abstract: Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.Type: GrantFiled: July 22, 2002Date of Patent: July 26, 2005Assignee: Advanced Viral Research Corp.Inventors: Bernard Friedland, Shalom Z. Hirschman, Irach B. Taraporewala
-
Patent number: 6696422Abstract: The present invention discloses a method of treating patients having AIDS or HIV infections by parenterally administering Product R, a peptide-nucleic acid preparation, in a combination with one or more antiviral agents useful for treating AIDS or HIV infections including HIV protease inhibitors and nucleoside analogs.Type: GrantFiled: May 21, 1999Date of Patent: February 24, 2004Assignee: Advanced Viral Research Corp.Inventor: Shalom Z. Hirschman
-
Publication number: 20040033244Abstract: A method of treating a patient suffering from cancers of lymph cells such as acute lymphocytic leukemia, chronic lymphocytic leukemia, Hodgkin's disease and non-Hodgkin's lymphoma comprises parenterally administering to said patient an effective acute lymphocytic leukemia treatment amount of Product R in a pharmaceutically acceptable formulation.Type: ApplicationFiled: May 28, 2003Publication date: February 19, 2004Applicant: Advanced Viral Research, Corp.Inventor: Shalom Z. Hirschman
-
Patent number: 6670118Abstract: The present invention discloses a method of treatment for patients having lesions resulting from papillomavirus infections by topically administering Product R, a peptide-nucleic acid preparation, to the lesions.Type: GrantFiled: November 10, 1998Date of Patent: December 30, 2003Assignee: Advanced Viral Research Corp.Inventor: Shalom Z. Hirschman
-
Publication number: 20030158107Abstract: Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.Type: ApplicationFiled: July 22, 2002Publication date: August 21, 2003Applicant: Advanced Viral Research Corp.Inventors: Bernard Friedland, Shalom Z. Hirschman, Irach B. Taraporewala
-
Publication number: 20030134782Abstract: Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.Type: ApplicationFiled: July 22, 2002Publication date: July 17, 2003Applicant: Advanced Viral Research Corp.Inventors: Bernard Friedland, Shalom Z. Hirschman, Irach B. Taraporewala
-
Patent number: 6528098Abstract: Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.Type: GrantFiled: January 17, 2001Date of Patent: March 4, 2003Assignee: Advanced Viral Research Corp.Inventors: Bernard Friedland, Shalom Z. Hirschman, Irach B. Taraporewala
-
Patent number: 6355226Abstract: A method of treating patients having viral infections including herpes simplex virus 1 and 2 infections and human papillomavirus infections by topically administering Product R, a peptide-nucleic acid preparation, by itself or in a composition comprising Product R and other pharmaceutically acceptable carriers for topical administration, is disclosed.Type: GrantFiled: August 30, 2000Date of Patent: March 12, 2002Assignee: Advanced Viral Research Corp.Inventor: Shalom Z. Hirschman
-
Publication number: 20020004579Abstract: Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.Type: ApplicationFiled: January 17, 2001Publication date: January 10, 2002Applicant: Advanced Viral Research Corp.Inventors: Bernard Friedland, Shalom Z. Hirschman, Irach B. Taraporewala
-
Patent number: 6303153Abstract: Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises nucleotides and peptides that have molecular weights not more than 14 KDa and substantially not more than 8 KDa. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.Type: GrantFiled: June 25, 1999Date of Patent: October 16, 2001Assignee: Advanced Viral Research Corp.Inventors: Bernard Friedland, Shalom Z. Hirschman
-
Patent number: 6268349Abstract: The present invention discloses a treatment for patients with the B19 parvovirus associated symptoms or patients carrying or infected by the B19 parvovirus or having antibodies against the B19 parvovirus using Product R, a peptide-nucleic acid preparation.Type: GrantFiled: April 15, 1997Date of Patent: July 31, 2001Assignee: Advanced Viral Research Corp.Inventor: Shalom Z. Hirschman
-
Patent number: 5902786Abstract: The present invention discloses a method for treating patients having basal cell carcinoma comprising subcutaneous, intralesional or topical administration of Product R, a peptide-nucleic acid preparation.Type: GrantFiled: April 15, 1997Date of Patent: May 11, 1999Assignee: Advanced Viral Research Corp.Inventor: William Bregman
-
Patent number: 5807839Abstract: The present invention discloses a method for treating anemia by stimulating red blood cells production by administering parenterally Product R, a peptide-nucleic acid preparation.Type: GrantFiled: April 15, 1997Date of Patent: September 15, 1998Assignee: Advanced Viral Research Corp.Inventor: Shalom Z. Hirschman
-
Patent number: 5807840Abstract: The present invention discloses a method for treating patients having the CDV associated symptoms or animals carrying or infected by the canine distemper virus (CDV) or having antibodies against the CDV using Product R, a peptide-nucleic acid preparation.Type: GrantFiled: November 4, 1997Date of Patent: September 15, 1998Assignee: Advanced Viral Research Corp.Inventor: Shalom Z. Hirschman